US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 10.520
  • -0.020-0.19%
Close Mar 7 16:00 ET
  • 11.600
  • +1.080+10.27%
Post 20:01 ET
524.27MMarket Cap-2.87P/E (TTM)

Mineralys Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-104.89%-166.31M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
Net income from continuing operations
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Depreciation and amortization
--43K
--15K
--11K
--9K
--8K
--0
--0
--0
--0
--0
Other non cash items
-37.00%-9.41M
35.29%-1.34M
-38.23%-2.71M
-43.64%-2.85M
-193.45%-2.51M
-957.78%-6.87M
-403.90%-2.07M
---1.96M
---1.98M
---855K
Change In working capital
227.47%9.52M
-394.83%-19.71M
39.02%5.72M
243.71%10.83M
20,885.25%12.68M
-1,067.62%-7.47M
-332.46%-3.98M
1,663.88%4.11M
-866.16%-7.54M
-106.28%-61K
-Change in receivables
219.44%424K
-67.33%98K
110.50%23K
210.84%184K
144.07%119K
---355K
--300K
---219K
---166K
---270K
-Change in prepaid assets
151.78%4.94M
-156.38%-3.13M
190.91%2.73M
132.71%1.18M
344.22%4.16M
-325.45%-9.53M
30.84%-1.22M
-464.66%-3M
-7,248.98%-3.6M
-1,676.85%-1.7M
-Change in payables and accrued expense
72.38%4.16M
-444.72%-16.67M
-59.60%2.96M
351.11%9.47M
339.38%8.4M
-19.82%2.42M
-461.82%-3.06M
2,627.14%7.34M
-465.15%-3.77M
121.30%1.91M
Cash from discontinued investing activities
Operating cash flow
-104.89%-166.31M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
Investing cash flow
Cash flow from continuing investing activities
171.64%114.96M
1,133.13%83.57M
1,886.65%79.61M
147.93%7.74M
60.11%-55.95M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
-16.14M
-140.25M
Net PPE purchase and sale
---96K
--0
---37K
--0
---59K
--0
--0
--0
--0
--0
Net investment purchase and sale
171.70%115.06M
1,133.13%83.57M
1,887.57%79.64M
147.93%7.74M
60.15%-55.89M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
---16.14M
---140.25M
Cash from discontinued investing activities
Investing cash flow
171.64%114.96M
1,133.13%83.57M
1,886.65%79.61M
147.93%7.74M
60.11%-55.95M
-637.50%-160.47M
-116.18%-8.09M
105.58%4.01M
---16.14M
---140.25M
Financing cash flow
Cash flow from continuing financing activities
-42.86%116.14M
21.62%90K
-100.54%-1K
73.84%-152K
-42.92%116.21M
58.76%203.25M
106.93%74K
132.80%184K
-100.49%-581K
1,596.85%203.57M
Net common stock issuance
-42.83%116.06M
--0
--0
89.67%-60K
-42.96%116.12M
12,561.02%202.99M
--0
--0
---581K
--203.57M
Proceeds from stock option exercised by employees
100.78%518K
85.14%137K
-78.26%40K
--192K
--149K
--258K
--74K
--184K
--0
--0
Net other financing activities
---435K
---47K
---41K
---284K
---63K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-42.86%116.14M
21.62%90K
-100.54%-1K
73.84%-152K
-42.92%116.21M
58.76%203.25M
106.93%74K
132.80%184K
-100.49%-581K
1,596.85%203.57M
Net cash flow
Beginning cash position
-43.78%49.3M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.3M
722.56%87.7M
76.28%86.3M
-21.15%101.14M
759.69%138.25M
722.56%87.7M
Current changes in cash
268.73%64.79M
145.46%16.82M
298.23%29.42M
39.20%-22.56M
-18.66%41.11M
-149.84%-38.4M
-195.48%-37M
81.29%-14.84M
-133.08%-37.11M
832.74%50.55M
End cash Position
131.40%114.09M
131.40%114.09M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.3M
-43.78%49.3M
76.28%86.3M
-21.15%101.14M
759.69%138.25M
Free cash flow
-105.01%-166.41M
-130.64%-66.84M
-163.90%-50.22M
-47.88%-30.15M
-50.28%-19.2M
-177.79%-81.17M
-184.52%-28.98M
-172.34%-19.03M
-272.76%-20.39M
-94.21%-12.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -104.89%-166.31M-130.64%-66.84M-163.71%-50.19M-47.88%-30.15M-49.82%-19.14M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M
Net income from continuing operations -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Depreciation and amortization --43K--15K--11K--9K--8K--0--0--0--0--0
Other non cash items -37.00%-9.41M35.29%-1.34M-38.23%-2.71M-43.64%-2.85M-193.45%-2.51M-957.78%-6.87M-403.90%-2.07M---1.96M---1.98M---855K
Change In working capital 227.47%9.52M-394.83%-19.71M39.02%5.72M243.71%10.83M20,885.25%12.68M-1,067.62%-7.47M-332.46%-3.98M1,663.88%4.11M-866.16%-7.54M-106.28%-61K
-Change in receivables 219.44%424K-67.33%98K110.50%23K210.84%184K144.07%119K---355K--300K---219K---166K---270K
-Change in prepaid assets 151.78%4.94M-156.38%-3.13M190.91%2.73M132.71%1.18M344.22%4.16M-325.45%-9.53M30.84%-1.22M-464.66%-3M-7,248.98%-3.6M-1,676.85%-1.7M
-Change in payables and accrued expense 72.38%4.16M-444.72%-16.67M-59.60%2.96M351.11%9.47M339.38%8.4M-19.82%2.42M-461.82%-3.06M2,627.14%7.34M-465.15%-3.77M121.30%1.91M
Cash from discontinued investing activities
Operating cash flow -104.89%-166.31M-130.64%-66.84M-163.71%-50.19M-47.88%-30.15M-49.82%-19.14M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M
Investing cash flow
Cash flow from continuing investing activities 171.64%114.96M1,133.13%83.57M1,886.65%79.61M147.93%7.74M60.11%-55.95M-637.50%-160.47M-116.18%-8.09M105.58%4.01M-16.14M-140.25M
Net PPE purchase and sale ---96K--0---37K--0---59K--0--0--0--0--0
Net investment purchase and sale 171.70%115.06M1,133.13%83.57M1,887.57%79.64M147.93%7.74M60.15%-55.89M-637.50%-160.47M-116.18%-8.09M105.58%4.01M---16.14M---140.25M
Cash from discontinued investing activities
Investing cash flow 171.64%114.96M1,133.13%83.57M1,886.65%79.61M147.93%7.74M60.11%-55.95M-637.50%-160.47M-116.18%-8.09M105.58%4.01M---16.14M---140.25M
Financing cash flow
Cash flow from continuing financing activities -42.86%116.14M21.62%90K-100.54%-1K73.84%-152K-42.92%116.21M58.76%203.25M106.93%74K132.80%184K-100.49%-581K1,596.85%203.57M
Net common stock issuance -42.83%116.06M--0--089.67%-60K-42.96%116.12M12,561.02%202.99M--0--0---581K--203.57M
Proceeds from stock option exercised by employees 100.78%518K85.14%137K-78.26%40K--192K--149K--258K--74K--184K--0--0
Net other financing activities ---435K---47K---41K---284K---63K--------------------
Cash from discontinued financing activities
Financing cash flow -42.86%116.14M21.62%90K-100.54%-1K73.84%-152K-42.92%116.21M58.76%203.25M106.93%74K132.80%184K-100.49%-581K1,596.85%203.57M
Net cash flow
Beginning cash position -43.78%49.3M12.72%97.27M-32.91%67.86M-34.60%90.42M-43.78%49.3M722.56%87.7M76.28%86.3M-21.15%101.14M759.69%138.25M722.56%87.7M
Current changes in cash 268.73%64.79M145.46%16.82M298.23%29.42M39.20%-22.56M-18.66%41.11M-149.84%-38.4M-195.48%-37M81.29%-14.84M-133.08%-37.11M832.74%50.55M
End cash Position 131.40%114.09M131.40%114.09M12.72%97.27M-32.91%67.86M-34.60%90.42M-43.78%49.3M-43.78%49.3M76.28%86.3M-21.15%101.14M759.69%138.25M
Free cash flow -105.01%-166.41M-130.64%-66.84M-163.90%-50.22M-47.88%-30.15M-50.28%-19.2M-177.79%-81.17M-184.52%-28.98M-172.34%-19.03M-272.76%-20.39M-94.21%-12.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More